Abstract
Aim:
To determine the distribution of cysteinyl leukotriene receptor 2 (CysLT2), one of the cysteinyl leukotriene receptors, in human brains with traumatic injury and tumors.
Methods:
Brain specimens were obtained from patients who underwent brain surgery. CysLT2 in brain tissues was examined using immunohistochemical analysis.
Results:
CysLT2 was expressed in the smooth muscle cells (not in the endothelial cells) of arteries and veins. CysLT2 was also expressed in the granulocytes in both vessels and in the brain parenchyma. In addition, CysLT2 was detected in neuron- and glial-appearing cells in either the late stages of traumatic injury or in the area surrounding the tumors. Microvessels regenerated 8 d after trauma and CysLT2 expression was recorded in their endothelial cells.
Conclusion:
CysLT2 is distributed in vascular smooth muscle cells and granulocytes, and brain trauma and tumor can induce its expression in vascular endothelial cells and in a number of other cells.
Similar content being viewed by others
Article PDF
References
Borish L . The role of leukotrienes in upper and lower airway inflammation and the implications for treatment. Ann Allergy Asthma Immunol 2002; 88: 16–22.
Fujita M, Yonetomi Y, Shimouchi K, Takeda H, Aze Y, Kawabata K, et al. Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs. Eur J Pharmacol 1999; 369: 349–56.
Storms WW . Minimal persistent inflammation, an emerging concept in the nature and treatment of allergic rhinitis: the possible role of leukotrienes. Ann Allergy Asthma Immunol 2003; 91: 131–40.
Shinonaga M, Chang CC, Kuwabara T . Relation between macrophage infiltrates and peritumoral edema. Adv Neurol 1990; 52: 475–81.
Schuhmann MU, Mokhtarzadeh M, Stichtenoth DO, Skardelly M, Klinge PM, Gutzki FM, et al. Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. Neurol Res 2003; 25: 481–91.
Ciceri P, Rabuffetti M, Monopoli A, Nicosia S . Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol 2001; 133: 1323–9.
Inamura T, Abe M, Ikezaki K, Fukui M . Leukotriene C4 contents, synthase and catabolic activity in human meningiomas. Neurol Res 1992; 14: 405–10.
Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999; 399: 789–93.
Sarau HM, Ames RS, Chambers J, Ellis C, Elshourbagy N, Foley JJ, et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 1999; 56: 657–63.
Takasaki J, Kamohara M, Matsumoto M, Saito T, Sugimoto T, Ohishi T, et al. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor. Biochem Biophys Res Commun 2000; 274: 316–22.
Hui Y, Yang G, Galczenski H, Figueroa DJ, Austin CP, Copeland NG, et al. The murine cysteinyl leukotriene 2 CysLT2 receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem 2001; 276: 47489–95.
Heise CE, O'Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 2000; 275: 30531–6.
Zhang WP, Hu H, Zhang L, Ding W, Yao HT, Chen KD, et al. Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumors. Neurosci Lett 2004; 363: 247–51.
Zhang WP, Wei EQ, Mei RH, Zhu CY, Zhao MH . Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats. Acta Pharmacol Sin 2002; 23: 871–7.
Kamohara M, Takasaki J, Matsumoto M, Matsumoto S, Saito T, Soga T, et al. Functional characterization of cysteinyl leukotriene CysLT2 receptor on human coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001; 287: 1088–92.
Sjostrom M, Johansson AS, Schroder O, Qiu H, Palmblad J, Haeggstrom JZ . Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: e37–41.
Lotzer K, Spanbroek R, Hildner M, Urbach A, Heller R, Bretschneider E, et al. Differential leukotriene receptor expression and calcium responses in endothelial cells and macrophages indicate 5-lipoxygenase-dependent circuits of inflammation and atherogenesis. Arterioscler Thromb Vasc Biol 2003; 23: e32–6.
Beller TC, Maekawa A, Friend DS, Austen KF, Kanaoka Y . Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem 2004; 279: 46129–34.
Ciccarelli R, D'Alimonte I, Santavenere C, D'Auro M, Ballerini P, Nargi E, et al. Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via CysLT1 receptors and mitogen-activated protein kinase pathway. Eur J Neurosci 2004; 20: 1514–24.
Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjolander A . Leukotriene D4 activates MAPK through a ras-independent but PKC ɛ-dependent pathway in intestinal epithelial cells. J Cell Sci 2002; 115: 1883–93.
Beller TC, Friend DS, Maekawa A, Lam BK, Austen KF, Kanaoka Y . Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci USA 2004; 101: 3047–52.
Evans JF . Cysteinyl leukotriene receptors. Prostaglandins Lipid Mediators 2002; 68–69: 587–97.
Di Gennaro A, Carnini C, Buccellati C, Ballerio R, Zarini S, Fumagalli F, et al. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: A role for transcellular biosynthesis of cysteinyl-leukotrienes. FASEB J 2004; 18: 842–4.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the National Natural Science Foundation of China (No 30271498) and the National Basic Research Program of China (No G1999054000).
Rights and permissions
About this article
Cite this article
Hu, H., Chen, G., Zhang, Jm. et al. Distribution of cysteinyl leukotriene receptor 2 in human traumatic brain injury and brain tumors. Acta Pharmacol Sin 26, 685–690 (2005). https://doi.org/10.1111/j.1745-7254.2005.00092.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00092.x
Keywords
This article is cited by
-
Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma
Cellular and Molecular Neurobiology (2018)
-
Interactions between prostaglandins, leukotrienes and HIV-1: Possible implications for the central nervous system
Retrovirology (2012)
-
Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cells
Journal of Neuroinflammation (2012)